TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34081085

Group type: EXPERIMENTAL
Intervention: Risk-reducing salpingo-oophorectomy (RRSO) without hormone replacement therapy
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Risk-reducing salpingo-oophorectomy (RRSO) with hormone replacement therapy
Number of subjects: 577

Group type: COMPARATOR
Intervention: Risk-reducing salpingectomy (RRS)
Number of subjects: 577
Study: 32522273

Group type: EXPERIMENTAL
Intervention: Standard dose Lingguizhugan decoction (SLGD)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Low dose Lingguizhugan decoction (LLGD)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study: 35051154

Group type: EXPERIMENTAL
Intervention: PE RA-TLIF
Number of subjects: 58

Group type: COMPARATOR
Intervention: MIS-TLIF
Number of subjects: 58
Study: 34693689

Group type: EXPERIMENTAL
Intervention: Recognan (citicoline), 500 mg daily for 30 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 54
Study: 32784231

Group type: EXPERIMENTAL
Intervention: Low-dose lidocaine (CIESI-L)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (CIESI-S)
Number of subjects: 120
Study: 33370208

Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT)
Number of subjects: 57
Study: 32103772

Group type: EXPERIMENTAL
Intervention: Team sport condition
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Individual sport condition
Number of subjects: 161

Group type: COMPARATOR
Intervention: Personal time control condition
Number of subjects: 161
Study: 36464137

Group type: EXPERIMENTAL
Intervention: Active TBS
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham TBS
Number of subjects: 28
Study: 32308168

Group type: EXPERIMENTAL
Intervention: Parenting-focused preventive intervention (11-session program)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Literature control condition
Number of subjects: 240
Study: 32187115

Group type: EXPERIMENTAL
Intervention: Cannabis use (including blunts)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Polytobacco product use (not including blunts)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 262
Study: 35223106

Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (TXA)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 204
Study: 34660913

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 12
Study: 36437161

Group type: EXPERIMENTAL
Intervention: ECAP-CL SCS
Number of subjects: 134
Study: 33978745

Group type: EXPERIMENTAL
Intervention: Zoledronate infusion after denosumab treatment (≤ 6 Group)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Zoledronate infusion after denosumab treatment (> 6 Group)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Comparison of LS-BMD changes between groups
Number of subjects: 47

Group type: COMPARATOR
Intervention: Correlation of denosumab treatment duration with LS-BMD change
Number of subjects: 47
Study: 32348248

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond 2 with light curing of both adhesive and cement
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: ExciTE F DSC with various light-curing and self-curing combinations
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Universal Primer with various light-curing and self-curing combinations
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All 3 adhesives with no light curing of adhesive or cement
Number of subjects: 3
Study: 36266501

Group type: EXPERIMENTAL
Intervention: HF-rTMS
Number of subjects: 56

Group type: COMPARATOR
Intervention: a-tDCS
Number of subjects: 56
Study: 34455443

Group type: EXPERIMENTAL
Intervention: Digital therapeutics group (HERB system + standard lifestyle modification)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group (standard lifestyle modification alone)
Number of subjects: 390
Study: 32958075

Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly (675 mg)
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: Fremanezumab monthly (675 mg)
Number of subjects: 1130
Study: 35488225

Group type: EXPERIMENTAL
Intervention: Vapocoolant spray
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 36
Study: 33477404

Group type: EXPERIMENTAL
Intervention: Tocotrienol-rich vitamin E (Tocovid SupraBioTM; Hovid Berhad, Ipoh, Malaysia) 400 mg daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 34120417

Group type: EXPERIMENTAL
Intervention: 0.1% nepafenac eye drops 4 times/day for 4 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: 1% prednisolone acetate eye drops in tapering doses for 4 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Both groups received moxifloxacin 0.5% eye drops 4 times/day for 2 weeks
Number of subjects: 200
Study: 32610257

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg/d)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 35835337

Group type: EXPERIMENTAL
Intervention: Tube shunt (350‐mm2 Baerveldt glaucoma implant)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC, 0.4 mg/ml for 2 minutes)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Tube shunt
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 242
Study: 33834971

Group type: EXPERIMENTAL
Intervention: Goal-oriented fluid resuscitation group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine fluid replacement group
Number of subjects: 60
Study: 36460983

Group type: EXPERIMENTAL
Intervention: eptinezumab 100 mg
Number of subjects: 890

Group type: EXPERIMENTAL
Intervention: eptinezumab 300 mg
Number of subjects: 890

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 890
Study: 33646129

Group type: EXPERIMENTAL
Intervention: Jaspr Health app (n=14)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Care as usual (control; n=17)
Number of subjects: 31
Study: 35544780

Group type: EXPERIMENTAL
Intervention: Silver-containing hydrofiber dressing (n = 16), not changed for 5 days after application.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard sterile gauze dressing (control group, n = 16), changed after 24 to 48 hours and replaced daily for 5 days.
Number of subjects: 32
Study: 32979635

Group type: EXPERIMENTAL
Intervention: Bioresorbable scaffold (BRS)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Metallic drug-eluting stent (DES)
Number of subjects: 56
Study: 35717049

Group type: EXPERIMENTAL
Intervention: Prone position, 5 fractions
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 57

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 57

Group type: COMPARATOR
Intervention: Supine position, 15 fractions
Number of subjects: 57
Study: 33081783

Group type: EXPERIMENTAL
Intervention: Accelerometer variables measured out-of-clinic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compensatory movement score derived from video analysis of the Action Research Arm Test (ARAT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Variables quantifying time, magnitude, and variability of upper limb movement out-of-clinic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Accelerometer variables measured in-clinic
Number of subjects: 0
Study: 36115789

Group type: EXPERIMENTAL
Intervention: Helfer skin tap technique (HSTT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine Technique (RT)
Number of subjects: 60
Study: 34483297

Group type: EXPERIMENTAL
Intervention: Combination cognitive behavioral therapy and medication management algorithm (COMB‐R)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Enhanced standard of care (control)
Number of subjects: 156
Study: 35384750

Group type: EXPERIMENTAL
Intervention: Core Training
Number of subjects: 84

Group type: COMPARATOR
Intervention: Core Training + Consultation
Number of subjects: 84
Study: 34348189

Group type: EXPERIMENTAL
Intervention: Empty Chair technique (EC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy technique (CT)
Number of subjects: 20
Study: 36259654

Group type: EXPERIMENTAL
Intervention: Cooling intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no cooling)
Number of subjects: 12
Study: 36264430

Group type: EXPERIMENTAL
Intervention: Ruxolitinib cream 0.75%
Number of subjects: 1249

Group type: EXPERIMENTAL
Intervention: Ruxolitinib cream 1.5%
Number of subjects: 1249

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 1249
Study: 34193885

Group type: EXPERIMENTAL
Intervention: Lipid composition analysis of plasma samples from ALS patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lipid composition analysis of plasma samples from PLS patients
Number of subjects: 0
Study: 32935320

Group type: EXPERIMENTAL
Intervention: Parkia platycephala pod meal (PP) and urea (1.5%)
Number of subjects: 4
Study: 35172747

Group type: EXPERIMENTAL
Intervention: Propofol-nalbuphine (PN) sedation
Number of subjects: 400

Group type: COMPARATOR
Intervention: Propofol-fentanyl (PF) sedation
Number of subjects: 400
Study: 33585890

Group type: EXPERIMENTAL
Intervention: IVIG + standard of care (SOC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 100
Study: 32133164

Group type: COMPARATOR
Intervention: IYCF + WASH (20g small-quantity lipid-based nutrient supplement/day from 6 to 18 months, complementary feeding counselling, pit latrine, 2 hand-washing stations, liquid soap, chlorine, play space, hygiene counselling)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SOC (standard-of-care)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IYCF
Number of subjects: 0

Group type: COMPARATOR
Intervention: WASH
Number of subjects: 0
Study: 35043140

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34100246

Group type: EXPERIMENTAL
Intervention: Laparoscopic redo Heller myotomy (HM)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (primary laparoscopic HM)
Number of subjects: 49
Study: 32340640

Group type: EXPERIMENTAL
Intervention: Nutrition education programme consisting of twelve 'hands on' nutrition education lessons delivered during the school year
Number of subjects: 523

Group type: COMPARATOR
Intervention: Control group (preschool classrooms not receiving the intervention)
Number of subjects: 523
Study: 33517454

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascia iliaca plane block
Number of subjects: 20
Study: 32332930

Group type: EXPERIMENTAL
Intervention: Genotype-based warfarin dosing
Number of subjects: 91

Group type: COMPARATOR
Intervention: Standard warfarin dosing
Number of subjects: 91
Study: 35270317

Group type: EXPERIMENTAL
Intervention: General practitioners in leadership positions (n = 84)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Employed general practitioners (n = 28)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Practice assistants (n = 254)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: General practitioners in leadership positions
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Employed physicians
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Practice assistants
Number of subjects: 366

Group type: COMPARATOR
Intervention: Full-time workers (general practitioners and practice assistants)
Number of subjects: 366
Study: 34585897

Group type: COMPARATOR
Intervention: Dapagliflozin
Number of subjects: 0
Study: 34284613

Group type: EXPERIMENTAL
Intervention: HTX-011
Number of subjects: 0

Group type: COMPARATOR
Intervention: bupivacaine HCl
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 32326325

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 26

Group type: COMPARATOR
Intervention: No drug (Control)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Endotoxin administration
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: P2Y12 inhibitors (Ticagrelor and Clopidogrel)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sepsis patients (n = 41 total; 12 with fatal outcomes, 29 survivors)
Number of subjects: 26
Study: 34879006

Group type: EXPERIMENTAL
Intervention: Cognitively Based Compassion Training (CBCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active-attention control
Number of subjects: 0
Study: 33070009

Group type: EXPERIMENTAL
Intervention: Buspirone (7.5 mg twice daily, titrated to maximum 30 mg twice daily)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 33547969

Group type: EXPERIMENTAL
Intervention: Single-cycle RIC
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Double-cycle RIC
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Both RIC protocols
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control group without RIC
Number of subjects: 270
Study: 35213875

Group type: EXPERIMENTAL
Intervention: Breathing exercises
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Cold exposure training
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Combination of cold exposure training and breathing exercise
Number of subjects: 88

Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 88
Study: 32701013

Group type: EXPERIMENTAL
Intervention: Five-peptide diagnostic model (m/z 1954.9, m/z 2081.0, m/z 3938.3, m/z 3946.5, and m/z 4268.8)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Five-peptide diagnostic model
Number of subjects: 67
Study: 34678177

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2000 IU/d)
Number of subjects: 11646

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11646
Study: 35320303

Group type: EXPERIMENTAL
Intervention: Hyperventilation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diaphragmatic breathing
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: First phone call (secondary stressor)
Number of subjects: 24
Study: 35921450

Group type: EXPERIMENTAL
Intervention: Cinpanemab 250 mg
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Cinpanemab 1250 mg
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Cinpanemab 3500 mg
Number of subjects: 357

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 357
Study: 32636281

Group type: EXPERIMENTAL
Intervention: Optimised background therapy (OBT) plus maraviroc (MVC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Optimised background therapy (OBT) alone
Number of subjects: 60
Study: 35248285

Group type: COMPARATOR
Intervention: Cervical stabilization exercises
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Scapular stabilization and upper limb proprioceptive exercises + cervical stabilization exercises
Number of subjects: 28
Study: 33812750

Group type: EXPERIMENTAL
Intervention: Family economic empowerment (EE) intervention plus bolstered standard of care
Number of subjects: 702

Group type: COMPARATOR
Intervention: Bolstered standard of care (control)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Caregiver social support
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Parent-child communication
Number of subjects: 702
Study: 33120324

Group type: EXPERIMENTAL
Intervention: Fordyce's fourteen Fundamentals for Happiness Program (8 one-hour group sessions)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional health-related education (4 one-hour group sessions)
Number of subjects: 70
Study: 35872875

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Obese control group
Number of subjects: 36
Study: 34029126

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser (3 W power, 300 mJ energy, 10 Hz frequency, long‐pulsed mode)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Surgical scalpel
Number of subjects: 11
Study: 35889936

Group type: COMPARATOR
Intervention: Isotretinoin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Isotretinoin + Evening Primrose Oil
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Isotretinoin and Isotretinoin + Evening Primrose Oil)
Number of subjects: 50
Study: 33907070

Group type: EXPERIMENTAL
Intervention: Rotary master apical file (RMAF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasonic activation of endodontic file (UAF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both RMAF and UAF
Number of subjects: 60
Study: 32417828

Group type: EXPERIMENTAL
Intervention: Voluntary shift work nurses
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Forced shift work nurses
Number of subjects: 1259
Study: 36241987

Group type: EXPERIMENTAL
Intervention: Online spiritual care training program (4 sessions over 4 weeks)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 95
Study: 33785651

Group type: EXPERIMENTAL
Intervention: ABBV-167 (prodrug of venetoclax)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Venetoclax tablets
Number of subjects: 0
Study: 32614368

Group type: EXPERIMENTAL
Intervention: Lidocaine (L‐SLNB)
Number of subjects: 40
Study: 33998885

Group type: EXPERIMENTAL
Intervention: Cannabidivarin (CBDV) 800 mg twice daily (b.i.d.)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Cannabidivarin (CBDV)
Number of subjects: 162
Study: 32356586

Group type: EXPERIMENTAL
Intervention: Oral methotrexate (MTX) plus narrowband ultraviolet light B (NB‐UVB) phototherapy, 10 mg oral MTX weekly and NB‐UVB sessions twice weekly for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral methotrexate (MTX) monotherapy, 10 mg oral MTX weekly
Number of subjects: 90
Study: 34314993

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure
Number of subjects: 119

Group type: COMPARATOR
Intervention: Seeking Safety
Number of subjects: 119
Study: 32183862

Group type: EXPERIMENTAL
Intervention: Caregiver Support Intervention (CSI)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 480
Study: 36028483

Group type: EXPERIMENTAL
Intervention: gemcitabine and nab-paclitaxel with durvalumab and tremelimumab
Number of subjects: 180

Group type: COMPARATOR
Intervention: gemcitabine and nab-paclitaxel
Number of subjects: 180
Study: 35842004

Group type: EXPERIMENTAL
Intervention: AZD5718 200 mg
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: AZD5718 50 mg
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 32593521

Group type: EXPERIMENTAL
Intervention: Genetically increased 25(OH)D level
Number of subjects: 7909
Study: 35294916

Group type: EXPERIMENTAL
Intervention: EUS-AG
Number of subjects: 58

Group type: COMPARATOR
Intervention: ERCP-BD
Number of subjects: 58
Study: 32183875

Group type: EXPERIMENTAL
Intervention: Autologous adipose-derived stem cells (ADSC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Incision-thread-drawing procedure (Control)
Number of subjects: 22
Study: 36284992

Group type: EXPERIMENTAL
Intervention: rosuvastatin, amlodipine, Ziyin Huoxue Recipe, and aspirin (experimental group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: rosuvastatin, amlodipine, Ziyin Huoxue Recipe (observation group)
Number of subjects: 60
Study: 33576537

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left DLPFC
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 19
Study: 32553835

Group type: EXPERIMENTAL
Intervention: 90-second animated video intervention
Number of subjects: 1051
Study: 34882092

Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33188208

Group type: EXPERIMENTAL
Intervention: Artificial nectar with added nicotine and anabasine (treatment)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Artificial nectar without added nicotine and anabasine (control)
Number of subjects: 16
Study: 35675174

Group type: EXPERIMENTAL
Intervention: Live group (LG)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Recorded group (RG)
Number of subjects: 83
Study: 34339231

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 32429733

Group type: EXPERIMENTAL
Intervention: Evervac vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: TBE-Moscow vaccine
Number of subjects: 0
Study: 34261160

Group type: EXPERIMENTAL
Intervention: Tourniquet used
Number of subjects: 101

Group type: COMPARATOR
Intervention: No tourniquet used
Number of subjects: 101
Study: 33648860

Group type: EXPERIMENTAL
Intervention: Nitrous oxide group
Number of subjects: 88

Group type: COMPARATOR
Intervention: Air group
Number of subjects: 88
Study: 32998931

Group type: EXPERIMENTAL
Intervention: Propranolol and etodolac
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35852684

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0
Study: 32893151

Group type: EXPERIMENTAL
Intervention: Alloderm
Number of subjects: 62

Group type: COMPARATOR
Intervention: Dermacell
Number of subjects: 62
Study: 35791584

Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 60
Study: 33454782

Group type: EXPERIMENTAL
Intervention: European cooperation packages with greater scope of medicines regulated
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Priority access to most in-need countries
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delegation to EU-level expertise
Number of subjects: 0
Study: 35395216

Group type: EXPERIMENTAL
Intervention: cCBT
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: cCBT+Telephone
Number of subjects: 176

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 176
Study: 34271271

Group type: EXPERIMENTAL
Intervention: Combined acupoints TEAS (PC6 and CV17)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Sham-operated control
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Single acupoint TEAS (PC6)
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Combined acupoint TEAS (PC6 and CV17)
Number of subjects: 576
Study: 35441899

Group type: EXPERIMENTAL
Intervention: Mobile device-based resilience training programme
Number of subjects: 21